United States · FDA National Drug Code directory

Guaifenesin

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
71335-9616_97d545be-a78d-48b5-b774-ded0e82d742f
Product NDC
71335-9616
Form
TABLET
Composition / generic term
Guaifenesin
Labeler
Bryant Ranch Prepack
Marketing category
OTC MONOGRAPH DRUG
Marketing start / end (source format)
20200801
Source listing expiry
20261231

Source-listed ingredients

  • GUAIFENESIN — 400 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 TABLET in 1 BOTTLE, PLASTIC (71335-9616-1) · 71335-9616-1
  • 20 TABLET in 1 BOTTLE, PLASTIC (71335-9616-2) · 71335-9616-2
  • 50 TABLET in 1 BOTTLE, PLASTIC (71335-9616-3) · 71335-9616-3
  • 60 TABLET in 1 BOTTLE, PLASTIC (71335-9616-4) · 71335-9616-4
  • 40 TABLET in 1 BOTTLE, PLASTIC (71335-9616-5) · 71335-9616-5

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →